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SUMMARY 
Outer membrane vesicles (OMVs) play an important role in the pathogenicity of Gram-
negative bacteria. Campylobacter jejuni produces OMVs that trigger IL-8, IL-6, hBD-3 and 
TNF-α responses from T84 intestinal epithelial cells and are cytotoxic to Caco-2 IECs and 
Galleria mellonella larvae. Proteomic analysis of 11168H OMVs identified the presence of 
three proteases, HtrA, Cj0511 and Cj1365c. In this study, 11168H OMVs were shown to 
possess proteolytic activity that was reduced by pre-treatment with specific serine protease 
inhibitors. OMVs isolated from 11168H htrA, Cj0511 or Cj1365c mutants possess significantly 
reduced proteolytic activity. 11168H OMVs are able to cleave both E-cadherin and occludin, 
but this cleavage is reduced with OMVs pre-treated with serine protease inhibitors and also 
with OMVs isolated from htrA or Cj1365c mutants. Co-incubation of T84 monolayers with 
11168H OMVs results in a visible reduction in both E-cadherin and occludin. The addition of 
11168H OMVs to the co-culture of live 11168H bacteria with T84 cells results in enhanced 
levels of bacterial adhesion and invasion in a time- and dose-dependent manner. Further 
investigation of the cleavage of host cell structural proteins by C. jejuni OMVs should enhance 
our understanding of the interactions of this important pathogen with intestinal epithelial cells. 
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INTRODUCTION 
The enteric pathogen Campylobacter jejuni is a Gram-negative, microaerophilic, spiral-shaped 
bacterium that is the leading cause of bacterial food-borne gastroenteritis worldwide (Epps et 
al., 2013). C. jejuni infection is associated with mild diarrhoea to severe inflammatory enteritis, 
although the mechanisms of pathogenesis are still poorly understood. In most cases, C. jejuni 
infection is self-limiting, but some cases (1:1000 to 1:2000) can develop serious life-
threatening complications, such as an acute autoimmune paralysing neuropathy Guillain–Barré 
syndrome (GBS) (Nyati et al., 2013). C. jejuni infection is a multistep process that includes 
colonisation of the intestinal mucosa, interactions with and invasion of the human intestinal 
epithelial cells (IECs) (Young et al., 2007). C. jejuni has been reported to invade human IECs 
either via paracellular or transcellular routes (Boehm et al., 2012, Ó Cróinín et al., 2012, 
Backert et al., 2013). C. jejuni involves the breach of the IEC barrier via paracellular invasion 
and binding to fibronectin located on the baso-lateral surface (Backert et al., 2013). Two 
adhesins (CadF and FlpA) facilitate the binding of C. jejuni to fibronectin (Monteville et al., 
2003, Konkel et al., 2010). However other virulence factors involved in the ability of C. jejuni 
to disrupt both tight junction (TJ) and adherens junction (AJ) proteins remain mostly 
uncharacterised (Boehm et al., 2012). 
TJs and AJs comprise two methods of cell-to-cell adhesion that provide different functions. TJ 
and AJ complexes are associated with the actin cytoskeleton, with formation and maturation of 
cell-to-cell contacts involving the reorganisation of the actin cytoskeleton (Hartsock et al., 
2008, Anderson et al., 2009, Liang et al., 2014, Van Itallie et al., 2014). TJs regulate the 
paracellular pathway for the movement of ions and solutes in-between cells. The 
transmembrane protein occludin is an important component of TJs (Cummins, 2012). AJs 
mediate the maturation and maintenance of cellular contact. The transmembrane protein E-
cadherin is an important component of AJs (van Roy et al., 2008, Maitre et al., 2013). Proteases 
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secreted by the closely related pathogen Helicobacter pylori compromise the integrity of AJs, 
allowing the bacteria access to the baso-lateral layer of gastric epithelial cells (Hoy et al., 2010). 
Other bacterial pathogens such as Shigella flexneri, disrupt the trafficking of cadherins, 
whereas Chlamydia species secrete proteases to exploit Golgi-derived membranes and create a 
specialised compartment suitable for bacterial survival and growth (Derre, 2015). Studies with 
enteric pathogens such as enteropathogenic Escherichia coli, Salmonella enterica and Shigella 
flexneri have revealed that these enteric pathogens breach the IEC TJ and AJ barrier function 
using type III secretion systems (T3SS) (Simonovic et al., 2000, Boyle et al., 2006). For 
example, enteropathogenic E. coli T3SS effectors disrupt TJ proteins in human IECs (Muza-
Moons et al., 2004, Viswanathan et al., 2004). However C. jejuni lacks a classical T3SS 
(Gundogdu et al., 2007). While the flagellar is proposed for the secretion of virulence proteins 
in a T3SS manner (Konkel et al., 2004), the few known examples of C. jejuni invasion antigens 
have not been shown to be involved in the breaching of the IECs barrier (Novik et al., 2010).  
Bacterial outer membrane vesicles (OMVs) have emerged as an important secretion 
mechanism for many Gram-negative pathogens (Bielaszewska et al., 2013, Altindis et al., 
2014, Bonnington et al., 2014, Scanlan, 2014). OMVs induce IECs antimicrobial immunity 
and apoptosis (Manning et al., 2011, Bielaszewska et al., 2013, Kaparakis-Liaskos et al., 
2015). C. jejuni produces OMVs that orchestrate pro-inflammatory cytokine responses from 
IECs (Elmi et al., 2012). Cytolethal distending toxin (CDT) is secreted within C. jejuni OMVs, 
which have been shown to be cytotoxic to Galleria mellonella wax worm larvae (Lindmark et 
al., 2009, Elmi et al., 2012, Jang et al., 2014). Although studies have focused on IECs cytokine 
responses to OMVs, the significance of other outcomes of OMV-host interactions are currently 
less studied. 
Proteases are critical for homeostasis (Clausen et al., 2011). One role of bacterial proteases is 
interacting with integral and peripheral barrier IECs proteins, resulting in cytotoxicity or 
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inflammation (Coleman et al., 2013, Sumitomo et al., 2013, Golovkine et al., 2014). Recent 
studies have shown that proteases from Bacteroides fragilis and Porphyromonas gingivalis 
breakdown E-cadherin, the predominant protein in epithelial AJs (Wu et al., 1998, Katz et al., 
2000, Remacle et al., 2014). Amongst the virulence proteins identified by proteomic analysis 
of C. jejuni 11168H OMVs were three proteases (Jang et al., 2014). The high temperature 
requirement protein (HtrA), Cj0511 and Cj1365c all share common features of serine proteases 
(Gundogdu et al., 2007). 
In this study, we demonstrate that C. jejuni 11168H OMVs possess proteolytic activity 
associated with the three proteases HtrA, Cj0511 and Cj1365c. OMV proteolytic activity was 
reduced by mutation of either htrA, Cj0511 or Cj1365c and also by pre-treatment of OMVs 
with specific serine protease inhibitors. 11168H OMVs directly cleave E-cadherin and 
occludin in vitro and this activity is associated with HtrA and Cj1365c protease activity but not 
with Cj0511. Co-incubation of T84 monolayers with C. jejuni 11168H OMVs results in a 
visible reduction in both E-cadherin and occludin. The addition of 11168H OMVs to the co-
culture of live 11168H bacteria with T84 IECs enhanced levels of bacterial adhesion and 
invasion in a time- and dose-dependent manner. Collectively, our data supports the hypothesis 
that OMVs impact on bacteria-IEC interactions by multiple mechanisms. 
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RESULTS  
C. jejuni 11168H OMVs possess serine-protease like activity 
The proteolytic activity of 11168H OMVs was quantified using a FITC-labelled casein assay 
using trypsin as a control (Fig. 1A). 10 g of 11168H OMVs yielded activity equivalent to 
approximately that observed with 10 ng/ml of trypsin. The proteolytic activity of 11168H 
OMVs was not reduced by pre-treatment with the protease inhibitors EDTA (metalloprotease 
inhibitor), E64 (cysteine protease inhibitor), Pepstatin A (aspartic protease inhibitor) and 
leupeptin (cysteine protease inhibitor) (Fig. 1B). However pre-treatment with the serine 
protease inhibitors phenylmethanesulfonyl fluoride (PMSF) and 4-(2-aminoethyl) 
benzenesulfonyl fluoride hydrochloride (AEBSF) significantly reduced 11168H OMVs 
proteolytic activity (Fig. 1B) suggesting that 11168H OMVs possess serine protease-like 
activity. The proteolytic activity of 11168H OMVs was further confirmed by casein and 
gelatin-substrate zymography (data not shown). 
 
Mutation of htrA, Cj0511 or Cj1365c significantly reduces OMVs proteolytic activity 
Having established that C. jejuni 11168H OMVs possess proteolytic activity, OMVs were 
isolated from 11168H htrA, Cj0511 and Cj1365c mutants and shown to possess a significantly 
reduced (all p < 0.001) proteolytic activity compared to the OMVs isolated from 11168H wild-
type strain (Fig. 2). Pre-treatment of OMVs isolated from the htrA, Cj0511 or Cj1365c mutants 
with the specific serine protease inhibitor PMSF significantly reduced (p < 0.001, p < 0.01 and 
p < 0.05 respectively) the proteolytic activity compared to similarly pre-treated 11168H OMVs. 
Pre-treatment of OMVs isolated from the htrA or Cj0511 mutants with the specific serine 
protease inhibitor AEBSF significantly reduced (both p < 0.001) the proteolytic activity 
compared to similarly pre-treated 11168H OMVs. However pre-treatment of OMVs isolated 
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from the Cj1365c mutant with AEBSF did not significantly reduce the proteolytic activity 
compared to similarly pre-treated 11168H OMVs. 
 
OMVs isolated from htrA or Cj1365c mutants exhibit reduced cytotoxicity in the Galleria 
mellonella model of infection 
C. jejuni 11168H OMVs have been shown to exhibit cytotoxicity in the G. mellonella larvae 
model of infection (Elmi et al., 2012). G. mellonella larvae were injected with OMVs (5 µg) 
isolated from 11168H wild-type strain, htrA, Cj0511 or Cj1365c mutants. At 24 h post-
infection, OMVs isolated from the htrA and Cj1365c mutants were significantly less cytotoxic 
(p < 0.001) than 11168H OMVs (Fig. 3). OMVs isolated from the Cj0511 mutant also showed 
reduced cytotoxicity but this difference was not significant compared to 11168H OMVs (Fig. 
3). No further mortality was observed at either 48 h or 72 h post-infection (data not shown). 
 
OMVs isolated from htrA, Cj0511 or Cj1365c mutants do not exhibit reduced cytotoxicity 
or immunogenicity to T84 IECs 
C. jejuni 11168H OMVs have been shown to exhibit cytotoxicity to IECs (Elmi et al., 2012). 
The cytotoxicity of OMVs on T84 IECs was measured by quantifying the release of cytosolic 
lactate dehydrogenase (LDH) as a measure of cell damage. OMVs (100 µg) were co-incubated 
with T84 IECs for 24 h. The cytotoxic effect of OMVs isolated from the htrA, Cj0511 or 
Cj1365c mutants was not statistically different to the cytotoxic effect of OMVs isolated from 
the 11168H wild-type strain (Fig. 4). 
C. jejuni 11168H OMVs have been shown to induce IL-8 from T84 IECs (Elmi et al., 2012). 
T84 cells were co-incubated with 11168H OMVs (1 µg, 10 µg or 100 µg) for 24 h and the 
levels of IL-8 secreted were measured by ELISA (Fig. 5). The levels of IL-8 induced by OMVs 
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isolated from either the htrA, Cj0511 or Cj1365c mutants was not statistically different to the 
levels induced by OMVs isolated from the 11168H wild-type strain. 
 
C. jejuni 11168H OMVs cleave E-cadherin and occludin 
C. jejuni invasion via the paracellular route is thought to involve cleavage of E-cadherin and 
occludin to allow the bacteria to reach the baso-lateral surface and to bind to fibronectin. Given 
the proteolytic activity associated with 11168H OMVs, the effect of OMVs on E-cadherin and 
occludin was investigated. Western blot analysis revealed 11168H OMVs cleave recombinant 
E-cadherin and release one major cleavage product of ∼85 kDa (Fig. 6A). Pre-treatment of 
11168H OMVs at either 100°C for 20 mins or with the specific serine protease inhibitor PMSF 
completely inhibited the cleavage of E-cadherin (Fig. 6B). E-cadherin was not cleaved in the 
presence of PBS alone. Similar results were observed with recombinant occludin (Fig. 6CD). 
Having established that C. jejuni OMVs cleave recombinant E-cadherin and occludin in vitro, 
we investigated whether C. jejuni OMVs cleave E-cadherin and occludin in T84 cells. T84 cell 
monolayers were co-incubated with 11168H OMVs for 3, 6 and 24 h. Immunofluorescence 
analysis revealed a reduction in both E-cadherin and occludin within monolayers at all three 
time points, in comparison to untreated monolayers (Fig. 7). 
 
HtrA and Cj1365c contribute to the OMV-induced cleavage of E-cadherin and occludin 
To investigate the role of the individual proteases associated with 11168H OMVs in the 
cleavage of E-cadherin or occludin, OMVs isolated from the htrA, Cj0511 or Cj1365c mutants 
were co-incubated with E-cadherin or occludin. Western blot analysis indicated that OMVs 
from the htrA and Cj1365c mutants exhibited reduced cleavage of E-cadherin, whilst OMVs 
from the Cj0511 mutant exhibited cleavage of E-cadherin similar to that of 11168H OMVs 
(Fig. 8A). Western blot analysis of OMVs from the htrA and Cj1365c mutants also exhibited 
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reduced cleavage of occludin, whilst OMVs from the Cj0511 mutant exhibited cleavage of 
occludin similar to that of 11168H OMVs (Fig. 8B). Taken together, the data indicated that 
Cj0511 does not target E-cadherin or occludin, in contrast HtrA and Cj1365c may both 
contribute to dysregulation of IEC barrier function. 
 
OMVs enhance C. jejuni 11168H invasion during co-culture with T84 IECs 
Having demonstrated that proteolytic activity is associated with C. jejuni OMVs, the role of 
OMVs during C. jejuni interactions with and invasion of IECs was investigated by adding 
11168H OMVs (1 µg or 10 µg) to the co-culture of live 11168H bacteria with T84 IECs (MOI 
100:1). The addition of OMVs had no significant effect on bacterial adhesion at 3 h, however 
there was a significant increase at both 6 h and 24 h (Fig. 9A). The addition of OMVs had a 
more marked effect on bacterial invasion, with significant increases observed at all time points 
with the numbers of intracellular bacteria increasing in an OMVs dose- and time-dependent 
manner (Fig. 9B). 
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DISCUSSION  
Recent characterisation of OMVs isolated from C. jejuni strains has provided important new 
insights into bacterial interactions with IECs (Lindmark et al., 2009, Elmi et al., 2012). In this 
study, we have demonstrated that 11168H OMVs contain three proteases, HtrA, Cj0511 and 
Cj1365c. To date, HtrA is the only C. jejuni protease with an identified host substrate, E-
cadherin (Boehm et al., 2012). Investigations into host substrates for other C. jejuni proteases 
have not yet been reported. Here, HtrA and Cj1365c proteases associated with C. jejuni OMVs 
were shown to be responsible for the cleavage of the major AJs and TJs proteins E-cadherin 
and occludin. The proteolytic activity of OMVs appears to play an important role in enhancing 
levels of C. jejuni interactions with and particularly invasion of IECs. The identification of the 
proteolytic activity associated with C. jejuni OMVs contributes to a growing appreciation that 
proteases play an important role in diverse aspects of bacterial pathogenesis. 
C. jejuni 11168H OMVs were shown to possess proteolytic activity with 10 g OMVs 
approximately equivalent to 10 ng/ml trypsin. To further investigate the proteolytic activity 
associated with C. jejuni OMVs, the ability of specific protease inhibitors to reduce OMVs 
proteolytic activity was investigated. Inhibitors of metalloproteases, cysteine proteases and 
aspartic proteases had no significant effect on OMVs proteolytic activity. In contrast, inhibitors 
of serine proteases significantly reduced OMVs proteolytic activity. Proteomic analysis has 
identified at least three proteases associated with C. jejuni OMVs (Elmi et al., 2012, Jang et 
al., 2014). OMVs isolated from htrA, Cj0511 or Cj1365c mutants possess significantly reduced 
proteolytic activity compared to OMVs isolated from the 11168H wild-type strain. The 
proteolytic activity of OMVs isolated from the htrA, Cj0511 or Cj1365c mutants was further 
reduced by pre-treatment with the specific serine protease inhibitors PMSF or AEBSF. 
However this reduction was much lower with the Cj1365c OMVs compared to either the htrA 
OMVs or Cj0511 OMVs, suggesting that the inhibitory effect of PMSF or AEBSF was much 
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less pronounced. Cj1365c OMVs would be expected to contain both HtrA and Cj0511 
proteases, so why the effect of serine protease inhibitors is less pronounced on OMVs isolated 
from the Cj1365c mutant is unclear. The Vibrio cholerae DegP protease has been shown to 
play an important role in determining the content of OMVs (Altindis et al., 2014), so Cj1365c 
could play a role incorporating HtrA and Cj0511 into OMVs and in the absence of Cj1365c, a 
yet unidentified protease is incorporated into OMVs in preference to HtrA and Cj0511. It is 
predicted that Campylobacter species encode as many as 64 peptidases (Karlyshev et al., 
2014). Proteomic analysis of OMVs isolated from the 11168H Cj1365c mutant would be a first 
step to testing this hypothesis. Originally it was considered that HtrA serine proteases play an 
important role as a bacterial cytoplasmic stress response factor, but more recently C. jejuni 
HtrA has been shown to be actively secreted and to interact with host protein E–cadherin 
resulting in bacterial paracellular transmigration (Boehm et al., 2012, Hoy et al., 2012). To our 
knowledge, this study represents the first demonstration that the C. jejuni HtrA and Cj1365c 
proteases cleave occludin. The reduced cleavage ability of OMVs isolated from the htrA or 
Cj1365c mutants suggests that both proteases can partially compensate for the absence of the 
other protease. The Cj0511 protease did not appear to contribute to OMV-induced cleavage of 
E-cadherin or occludin in vitro. Cj0511 was recently characterised as a serine protease with a 
role in bacterial colonisation (Karlyshev et al., 2014). It is possible that Cj0511 plays a role in 
the degradation of mucin to promote colonisation in vivo or as a source of nutrients, whilst the 
HtrA and Cj1365c proteases play roles in bacterial interactions with host cells. Recently, 
studies have shown Bacteroidales species secrete glycoside hydrolases and polysaccharide in 
OMVs, which allow other species to utilise plant polysaccharides that would otherwise be 
inaccessible as a source of nutrients (Elhenawy et al., 2014). As such OMVs could play a role 
in C. jejuni competitive and beneficial interactions with host substrates. 
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The proteolytic activity associated with Cj1365c supports the annotation of Cj1365c as a 
putative serine protease with a predicted molecular size of 116.3 kDa. Cj1365c also has the 
characteristic modular organisation of an autotransporter. Bioinformatic analysis predicts that 
Cj1365c contains an N-terminal signal sequences (1-15) followed by a Peptidase S8 domain 
(34-346) and a C-terminal autotransporter domain (786-1007) 
(www.uniprot.org/uniprot/Q0P8P4) (see Figure S1A). Bioinformatic analysis predicts that 
HtrA contains a Peptidase S46 domain (104-239) (www.uniprot.org/uniprot/Q0P928) and 
Cj0511 contains a Peptidase S41 domain (208-369) (www.uniprot.org/uniprot/Q0PB04) (see 
Figure S1A). The predicted active sites for serine protease activity associated with Cj1365c 
(D43 / H80 / S292), HtrA (H120 / D151 / S225) and Cj0511 (S303 / K328) are indicated in a 
sequence alignment of the three proteases (Figure S1B). Blast searching of the MEROPS 
database (http://merops.sanger.ac.uk/) has also confirmed Cj1365c has a subtilisin-like 
protease motif, which shares 30% sequence identity with the extracellular subtilisin from 
Serratia marcescens. Cj1365c has been reported to be absent in C. jejuni strains isolated from 
environmental sources, but present in the large majority (88.6%) of clinical isolates, suggesting 
that Cj1365c may be associated with C. jejuni host adaptation and virulence (Champion et al., 
2005). The fact that the HtrA, Cj0511 and Cj1365c proteases are associated with a serine motif 
to facilitate substrate recognition supports the hypothesis that C. jejuni serine proteases play an 
important role in virulence. Proteases from several bacterial pathogens have been demonstrated 
to cleave IEC proteins including E-cadherin (Costa et al., 2013). 
Previously we have shown that the cytotoxicity associated with C. jejuni OMVs in the G. 
mellonella larvae model was independent of CDT (Elmi et al., 2012). In contrast, this study 
has shown that both HtrA and Cj1365c play a role in OMVs cytotoxicity to G. mellonella 
larvae. Studies have shown that C. jejuni protease mutants exhibit reduced G. mellonella 
cytotoxicity (Champion et al., 2010). However, the fact that OMVs isolated from the Cj0511 
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mutant exhibit a non-significant decrease in cytotoxicity compared to wild-type OMVs 
suggests that Cj0511 may not play a role in OMVs cytotoxicity to G. mellonella larvae. 
Recombinant proteases from other pathogenic bacteria have been shown to cause destruction 
of the G. mellonella coagulation response and activation of hemolymph melanisation, which 
results in larval death. For example, Pseudomonas aeruginosa protease IV is a key virulence 
factor that may modulate the host innate immune system and elastase B might contribute to P. 
aeruginosa pathogenesis (Park et al., 2014). C. jejuni HtrA has been shown to play a role in 
acute ulcerative enterocolitis and extra-intestinal immune responses during bacterial infection 
of gnotobiotic IL-10 deficient mice (Heimesaat et al., 2014b) and C. jejuni htrA mutant 
infection of an infant mouse model system resulted in reduced intestinal and extra-intestinal 
pro-inflammatory immune responses (Heimesaat et al., 2014a).  
The increase in bacterial adhesion and invasion of IECs in the presence of OMVs may be 
explained in part by the presence of HtrA, Cj0511 and Cj1365c, which may be acting in a 
concerted fashion, leading to increased accessibility of C. jejuni to the sub-cellular space 
receptors. The ability of C. jejuni to adhere to and invade IECs is reduced by mutation of htrA 
(Brondsted et al., 2005, Boehm et al., 2015), Cj0511 (Jowiya et al., 2013) or Cj1365c (data not 
shown). C. jejuni infection of T84 cells results in a time-dependent decrease in transepithelial 
electrical resistance (TEER) and a redistribution of occludin from an intercellular to an 
intracellular location (Chen et al., 2006). Previously the cleavage of occludin by C. jejuni has 
been suggested to occur via an as yet unknown mechanism(s) (MacCallum et al., 2005). The 
in vitro time-dependent cleavage of E-cadherin and occludin and the visible reduction in E-
cadherin and occludin associated with T84 monolayers after incubation with C. jejuni OMVs 
both support the role of these proteases in the mechanism(s) resulting in increased bacterial 
adhesion and invasion in the presence of OMVs. This is consistent with the recent report of the 
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role of HtrA in C. jejuni transmigration of IECs, suggesting new outlooks on the mechanisms 
used by this important enteric pathogen to interact with and invade IECs (Boehm et al., 2012). 
The data in this study adds to a growing body of evidence that the release of OMVs plays an 
important role in bacterial pathogenesis. C. jejuni OMVs possess proteolytic activity in vitro, 
which can be inhibited by specific serine protease inhibitors. This OMVs proteolytic activity 
is associated with the HtrA, Cj0511 and Cj1365c proteases. Both the HtrA and Cj1365c 
proteases are involved in the C. jejuni OMV-induced proteolytic cleavage of E-cadherin and 
occludin. In addition OMVs increased the numbers of live C. jejuni interacting with and 
invading IECs in a time- and dose-dependent manner. Further investigations into the molecular 
mechanism(s) by which proteases modulate TJs and AJs proteins and IEC barrier function are 
required. How C. jejuni OMV-induced proteolytic cleavage of TJs and AJs proteins is 
modulated by physiological or pathological stimuli in vivo is a novel area of pathogenesis 
requiring further investigation. A greater understanding of the role that C. jejuni OMVs play 
during bacterial interactions with host cells will allow new insights into how this important 
pathogen interacts with IECs and causes disease. 
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EXPERIMENTAL PROCEDURES 
Bacterial strains and culture conditions 
The C. jejuni wild-type strain used in this study was 11168H, a hypermotile derivative of the 
sequence strain NCTC11168 that shows higher levels of caecal colonisation in a chick 
colonisation model (Jones et al., 2004). The C. jejuni 11168H htrA, Cj0511 and Cj1365c 
mutants were obtained from the LSHTM Campylobacter Resource Facility 
(http://crf.lshtm.ac.uk/index.htm). All mutations were confirmed by PCR screening and by 
sequencing as described previously (Gundogdu et al., 2011). C. jejuni strains were grown either 
on blood agar plates containing Columbia agar base (Oxoid, UK) supplemented with 7% (v/v) 
horse blood (TCS Microbiology, UK) and Campylobacter Selective Supplement (Oxoid) or in 
Brucella broth (Oxoid) with shaking at 75 rpm in a microaerobic chamber (Don Whitley 
Scientific, UK) containing 85% N2, 10% CO2 and 5% O2 at 37°C. Kanamycin (Sigma-Aldrich, 
UK) was added to blood agar plates or to Brucella broth as required at the concentration of 50 
μg/ml. Unless otherwise stated, C. jejuni strains were grown on blood agar plates for 24 h prior 
to use in all subsequent experiments. 
 
Isolation of C. jejuni OMVs 
C. jejuni OMVs were isolated as described previously (Elmi et al., 2012). C. jejuni from a 24 h 
blood agar plate were resuspended in 1 ml Brucella broth and used to inoculate 100 ml pre-
equilibrated Brucella broth to an OD600 of 0.1. Cultures were grown for 14 h to mid-log phase 
then centrifuged at 10,000 x g for 15 mins at 4°C. The resulting supernatant was filtered 
through a 0.22 m membrane (Millipore, UK) then the filtrate concentrated to 2 ml using an 
Ultra-4 Centrifugal Filter Unit with a nominal 10 kDa cutoff (Millipore). The concentrated 
filtrate was ultra-centrifuged at 150,000 x g for 3 h at 4°C using a TLA 100.4 rotor (Beckman 
Instruments, USA). All isolation steps were carried out at 4°C and the resulting OMV pellet 
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was resuspended in phosphate buffered saline (PBS) and stored at -20°C. OMV samples were 
plated out on blood agar plates and incubated under both microaerobic and aerobic conditions 
for 48 h to confirm the absence of viable bacteria. Approximately 200 g OMVs by protein 
content were isolated from 100 ml of culture supernatant, determined by BCA assay (Fisher 
Scientific, UK). Amounts of OMVs used in subsequent experiments are quantified by protein 
content. 
 
Quantitative determination of OMVs proteolytic activity 
The proteolytic activity of OMVs was determined using a Protease Fluorescent Detection Kit 
(Sigma-Aldrich) using a FITC-labelled casein substrate. OMVs (10 g in 10 µl) were mixed 
with 20 µl incubation buffer and 20 l substrate then incubated at 37°C in the dark for 24 h. 
The reaction was stopped by adding 200 µl 0.6 N trichloroacetic acid to precipitate any 
remaining substrate, which was removed by centrifugation at 10,000 x g for 10 mins at 4°C. 
The supernatant obtained (10 l) was diluted in 1 ml assay buffer. The digested FITC-casein 
substrate has absorption / emission maxima at 485 nm / 535 nm, and fluorescence intensity was 
recorded using a Multi-Mode Microplate reader (Molecular Devices, UK). Bovine trypsin (1 
µg/ml) was used as positive control in all experiments. 
The effects of different protease inhibitors (EDTA, E64, pepstatin A, leupeptin, PMSF and 
AEBSF) on proteolytic activity were determined by pre-incubating 10 g OMVs with 1 l of 
each inhibitor (Protease Inhibitor Set, G-Biosciences, U.S.A) in PBS at 37°C for 30 mins before 
incubation with FITC-labelled casein substrate at 37°C in the dark for 24 h. Appropriate 
controls (no substrate and no enzyme) were performed. 
 
Galleria mellonella larvae model of infection 
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G. mellonella larvae (LiveFoods Direct, UK) were kept on wood chips at 16°C. Experiments 
were performed with slight modifications from the original published methodology (Champion 
et al., 2010) as described previously (Gundogdu et al., 2011). Briefly, 5 µg of 11168H, htrA, 
Cj0511 or Cj1365c OMVs in a 10 l volume were injected into the right foremost leg of the 
G. mellonella larvae by micro-injection (Hamilton, Switzerland). For each experiment, 10 G. 
mellonella larvae were injected and experiments were repeated three times where larvae of the 
same approximate weight were chosen. Controls were both non-injected larvae or larvae 
injected with 10 l of sterile PBS. Larvae were incubated at 37°C and survival recorded at 24 
h intervals for 72 h. 
 
Cell lines, media and culture conditions 
The human T84 colon cancer epithelial cells were obtained from the National Type Culture 
Collection. T84 cells were maintained at sub-confluence in DMEM / F-12 (Invitrogen, UK) 
supplemented with 10% (v/v) FCS, 1% (w/v) non-essential amino acids and 1% (w/v) 
penicillin-streptomycin (Sigma-Aldrich) at 37°C in a 5% CO2 humidified atmosphere. Cells 
were split around 80-90% confluence and seeded at 5 x 105 cells per well into 24-well tissue 
culture plates (Corning Glass Works, Netherlands) using 1 ml volumes of cell culture media 
per well. Medium was replenished every 2 days. For ELISA experiments, the medium was 
removed and monolayers washed three times with PBS, then maintained in antibiotic-free 
medium supplemented with 10% (v/v) serum (Invitrogen) for 24 h before each experiment. 
 
Cytotoxicity detection assay 
The CytoTox 96® non-radioactive cytotoxicity assay (Promega, UK) was used to quantify the 
cell damage induced by co-culture with C. jejuni OMVs. Briefly, T84 cells were challenged 
with 100 g of 11168H, htrA, Cj0511 or Cj1365c OMVs. After co-incubation at 37°C for 24 
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h, cell supernatants were analysed for the release of lactate dehydrogenase (LDH). Non-
challenged cells represented the 0% cytotoxicity negative control. Total lysis of cells following 
treatment with 1% (v/v) Triton X-100 represented the 100% cytotoxicity positive control. 
 
Enzyme-linked immunosorbent assay (ELISA) 
T84 cells were co-cultured with 100 g, 10 g or 1 g of 11168H OMVs or htrA, Cj0511 or 
Cj1365c OMVs for 24 h. The levels of IL-8 secretion were assessed using a commercially 
available sandwich ELISA kit according to manufacturer’s instructions (E-Biosciences, UK). 
Detection was performed using a Dynex MRX II 96 well plate reader (Dynex, U.S.A) at an 
absorbance of 450 nm (A450) and analysed using Revelation software (Dynex). 
 
in vitro cleavage of E-cadherin and occludin by C. jejuni OMVs 
The cleavage of recombinant TJs and AJs proteins (E-cadherin and occludin) by 11168H 
OMVs or htrA, Cj0511 or Cj1365c OMVs was determined as described previously (Baek et 
al., 2011). Briefly, OMVs (10 µg) were incubated with 1 µg recombinant human E-cadherin 
or occludin (R&D Systems, UK) in PBS at 37°C for 3 and 16 h. For analysis of E-cadherin or 
occludin cleavage, reactions were mixed with 2X sample loading buffer (125 mM Tris-HCl 
(pH 6.8), 2% (w/v) SDS, 10% (v/v) 14.3 M β-mercaptoethanol, 10% (v/v) glycerol, 0.006% 
(w/v) bromophenol blue) and boiled for 10 min. Proteins were separated using NuPAGE® 
Novex® 12% Bis-Tris protein gels (Invitrogen) then electrotransferred onto a nitrocellulose 
blotting membrane (GE Healthcare, UK) using the Semi-dry Trans-Blot system (GE 
Healthcare). Membranes were incubated in a blocking buffer (2% (w/v) skimmed milk (Tesco, 
UK) in PBS) for 1 h at room temperature. After removal of blocking buffer, membranes were 
rinsed three times with 0.1% (v/v) Tween-20 in PBS then incubated 1 h at room temperature 
with primary mouse anti-E-Cadherin or primary rabbit anti-occludin (Abcam, UK) (1:1,000). 
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Following primary antibody incubation, membranes were washed four times with 0.1% (v/v) 
Tween-20 in PBS followed by incubation with an infrared fluorescence-conjugated secondary 
antibody (either goat anti-mouse IR800 or goat anti-rabbit IR680 (Licor Biosciences, UK) 
prepared in a 1:10,000 dilution of blocking buffer) at room temperature for 1 h. Membranes 
were scanned and analysed using a Licor Odyssey® (Licor Biosciences). 
 
Immunofluorescence staining of T84 cells 
T84 cells were grown on glass coverslips (thickness 0.16 ± 0.005 mm; VWR, UK) in 24-well 
plates. Cells were incubated with 10 µg of C. jejuni 11168H OMVs. After 3, 6 and 24 h, cells 
were washed twice with PBS and fixed with 4% (v/v) paraformaldehyde (VWR) in PBS for 20 
min at room temperature. After three washes with PBS, cells were permeabilised with 0.1% 
(v/v) Triton X-100 in PBS at room temperature for 30 min. Cells were washed three times with 
PBS and blocked with 3% (w/v) bovine serum albumin (BSA) (Sigma-Aldrich) in PBS for 1 
h. Following blocking, cells were incubated with anti-E-cadherin (1: 400) or anti-occludin 
(1: 400) (Abcam) in blocking buffer for 1 h at room temperature. Cells were washed three times 
with PBS and incubated with secondary antibodies (anti‐mouse IgG Alexa Fluor 488 (1:1000) 
or anti‐rabbit IgG Alexa Fluor 488 (1:1000) (Invitrogen) in blocking buffer for 1 h. After 
washing, coverslips were mounted with Vectashield with DAPI (Vector Labs, UK). Images 
were captured on a confocal microscope (Zeiss LSM 510 confocal microscope (Carl Zeiss, 
Jena, Germany)) then processed in LSM 510 Image Browser. Laser intensity was kept 
consistent between samples. 
 
Interaction and invasion assays 
T84 cell monolayers (∼80% confluence in 24-well tissue culture plates) were infected with 
bacteria at a multiplicity of infection (MOI) of 100:1 for 3, 6 or 24 h as described previously 
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(Elmi et al., 2012). For interaction experiments, the monolayers were washed three times with 
PBS then lysed with 0.2% (v/v) Triton X-100. The cell lysates were serially diluted, 200 l 
volumes plated onto blood agar plates and incubated for 72 h before colonies were counted. 
For invasion experiments, the monolayers were washed three times with PBS, incubated in cell 
culture medium containing gentamicin (150 μg/ml) for 2 h at 37°C to kill extracellular bacteria, 
then treated as for the interaction experiments. 
 
Statistical analysis 
All experiments represent at least three biological replicates with each experiment performed 
in triplicate. All data were analysed using Prism statistical software (Version 6, GraphPad 
Software, USA). Values were expressed as mean ± SEM. Variables were compared for 
significance using Two-Way Analysis of Variance (ANOVA) and the Bonferroni test with one 
asterisk (*) indicating a p value between 0.01 and 0.05, two asterisks (**) indicating a p value 
between 0.001 and 0.01 and three asterisks (***) indicating a p value < 0.001. 
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FIGURE LEGENDS 
FIG. 1. C. jejuni 11168H OMVs possess proteolytic activity. (A) Quantification of protease 
activity of C. jejuni 11168H OMVs compared to trypsin. Protease activity was detected after 
incubating FITC-labelled casein substrate with OMVs or trypsin at 37°C in the dark for 24 h. 
(B) Quantification of protease activity of C. jejuni 11168H OMVs in the presence of different 
protease inhibitors. Protease activity is expressed as the percentage of untreated 11168H OMVs 
(defined as 100%). *** = p < 0.001, ns = no significant difference. 
 
FIG. 2. OMVs isolated from Cj0511, Cj1365c and htrA mutants display significantly 
reduced proteolytic activity compared to 11168H OMVs. Quantification of protease activity 
of OMVs isolated from C. jejuni 11168H wild-type strain, Cj0511, Cj1365c or htrA mutants 
in the absence or presence of specific serine inhibitors AEBSF or PMSF. Protease activity is 
expressed as the percentage of untreated 11168H OMVs (defined as 100%). * = p < 0.05, ** = 
p < 0.01, *** = p < 0.001. 
 
FIG. 3. OMVs isolated from Cj1365c and htrA mutants display a significant reduced 
cytotoxicity in G. mellonella larvae. G. mellonella larvae were injected with a 10 μl inoculum 
of 11168H OMVs (5 μg) or Cj0511, Cj1365c and htrA OMVs (5 μg) by microinjection in the 
right foremost leg. Larvae were incubated at 37°C and survival recorded after 24 h. PBS and 
no injection controls were also performed. For each experiment, 10 G. mellonella larvae were 
infected and experiments were performed in triplicate. *** = p < 0.001, ns = no significant 
difference. 
 
FIG. 4. Cytotoxic effect of OMVs isolated from 11168H, Cj0511, Cj1365c and htrA 
mutants on T84 cells. The cytotoxic effect on the T84 cells was quantified by the release of 
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cytosolic lactate dehydrogenase (LDH) as a measure of cell damage. Non-challenged T84 cells 
represented 0% cytotoxicity (Uninfected Cells) and total lysis of T84 cells following treatment 
with 1% (v/v) Triton X-100 represented 100% cytotoxicity (Positive control). 
 
FIG. 5. Induction of IL-8 from T84 intestinal epithelial cells by OMVs isolated from 
11168H, Cj0511, Cj1365c and htrA mutants. T84 IECs responses to 24 h co-incubation with 
OMVs isolated from C. jejuni 11168H wild-type strain, Cj0511, Cj1365c or htrA mutants (100 
g, 10 µg or 1 g) were assessed. Levels of IL-8 secreted from T84 cells following co-
incubation with OMVs were quantified using a human IL-8 ELISA. ** = p < 0.01; *** = p < 
0.001; ns = no significant difference. 
 
FIG. 6. C. jejuni 11168H OMVs cleaves E-Cadherin and occludin in vitro. (A&B) 
Recombinant E-cadherin was incubated with 10 g of 11168H OMVs, heat treated OMVs or 
phenylmethanesulfonyl fluoride (PMSF) treated OMVs for 3 h or 16 h as indicated at 37°C. 
Samples were separated by SDS-PAGE under reducing conditions and cleavage was detected 
by Western blotting with anti-E-cadherin antibody. (C&D) Recombinant occludin was 
incubated with 10 g of 11168H OMVs, heat treated OMVs or phenylmethanesulfonyl fluoride 
(PMSF) treated OMVs for 3 h or 16 h as indicated at 37°C. Samples were separated by SDS-
PAGE under reducing conditions and cleavage was detected by Western blotting with anti-
occludin antibody. The position of molecular mass markers (kDa) is indicated to the left of the 
blot. 
 
FIG. 7. Co-incubation of C. jejuni 11168H OMVs with T84 intestinal epithelial cell 
monolayers results in a visible reduction in E-cadherin and occludin. T84 IECs were co-
incubated with 11168H OMVs (10 g) for 3 h, 6 h and 24 h. The cells were fixed, permeabilised 
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and probed with E-cadherin (Top Panel) or occludin (Bottom Panel) antibodies. Untreated T84 
cells were included as a control (Left Panels). White arrowheads indicate gap between cells 
where E-cadherin or occludin is disrupted in T84 IECs co-incubated with OMVs.  
 
FIG. 8. Reduction in cleavage of E-Cadherin or occludin by OMVs isolated from htrA 
and Cj1365c mutants. Recombinant E-cadherin (A) or occludin (B) was incubated with 
OMVs isolated from C. jejuni 11168H wild-type strain, Cj0511, Cj1365c or htrA mutants as 
indicated. Samples were separated by SDS-PAGE and subjected to Western blot analysis using 
anti-E-cadherin or anti-occludin antibody. The position of molecular mass markers (kDa) is 
indicated to the left of the blot. 
 
FIG. 9. Co-incubation of C. jejuni 11168H OMVs with intestinal epithelial cells prior to 
co-culture enhances bacterial invasion. T84 IECs were co-incubated with 11168H OMVs 
(10 g or 1 g) during infection with live C. jejuni 11168H (MOI 100:1). T84 cells were either 
lysed and numbers of interacting bacteria assessed (A) or incubated with gentamicin (150 
μg/ml) for 2 h to kill extracellular bacteria, then lysed and numbers of intracellular bacteria 
assessed (B). * = p < 0.05; *** = p < 0.001. 
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